vs
Side-by-side financial comparison of GE HealthCare (GEHC) and US Foods Holding Corp. (USFD). Click either name above to swap in a different company.
US Foods Holding Corp. is the larger business by last-quarter revenue ($9.8B vs $5.1B, roughly 1.9× GE HealthCare). GE HealthCare runs the higher net margin — 8.0% vs 1.9%, a 6.1% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.4% vs 3.3%). US Foods Holding Corp. produced more free cash flow last quarter ($159.0M vs $112.0M). Over the past eight quarters, US Foods Holding Corp.'s revenue compounded faster (4.6% CAGR vs 3.0%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
US Foods Holding Corp. is an American food service distributor. It is the second-largest food service distributor in the U.S., after Sysco. The company supplies 250,000 locations including independent restaurants, chain restaurants, healthcare, hospitality, and educational institutions.
GEHC vs USFD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $9.8B |
| Net Profit | $411.0M | $184.0M |
| Gross Margin | 38.5% | 17.6% |
| Operating Margin | 10.0% | 3.3% |
| Net Margin | 8.0% | 1.9% |
| Revenue YoY | 7.4% | 3.3% |
| Net Profit YoY | -30.1% | 178.8% |
| EPS (diluted) | $0.85 | $0.82 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.7B | $9.8B | ||
| Q3 25 | $5.1B | $10.2B | ||
| Q2 25 | $5.0B | $10.1B | ||
| Q1 25 | $4.8B | $9.4B | ||
| Q4 24 | $5.3B | $9.5B | ||
| Q3 24 | $4.9B | $9.7B | ||
| Q2 24 | $4.8B | $9.7B |
| Q1 26 | $411.0M | — | ||
| Q4 25 | $588.0M | $184.0M | ||
| Q3 25 | $446.0M | $153.0M | ||
| Q2 25 | $486.0M | $224.0M | ||
| Q1 25 | $564.0M | $115.0M | ||
| Q4 24 | $721.0M | $66.0M | ||
| Q3 24 | $470.0M | $148.0M | ||
| Q2 24 | $428.0M | $198.0M |
| Q1 26 | 38.5% | — | ||
| Q4 25 | 39.7% | 17.6% | ||
| Q3 25 | 38.7% | 17.2% | ||
| Q2 25 | 39.6% | 17.6% | ||
| Q1 25 | 42.1% | 17.3% | ||
| Q4 24 | 42.8% | 17.6% | ||
| Q3 24 | 41.7% | 17.1% | ||
| Q2 24 | 41.4% | 17.6% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 14.5% | 3.3% | ||
| Q3 25 | 12.7% | 2.8% | ||
| Q2 25 | 13.1% | 3.7% | ||
| Q1 25 | 13.2% | 2.4% | ||
| Q4 24 | 15.1% | 3.2% | ||
| Q3 24 | 13.9% | 2.9% | ||
| Q2 24 | 12.6% | 3.6% |
| Q1 26 | 8.0% | — | ||
| Q4 25 | 10.3% | 1.9% | ||
| Q3 25 | 8.7% | 1.5% | ||
| Q2 25 | 9.7% | 2.2% | ||
| Q1 25 | 11.8% | 1.2% | ||
| Q4 24 | 13.6% | 0.7% | ||
| Q3 24 | 9.7% | 1.5% | ||
| Q2 24 | 8.8% | 2.0% |
| Q1 26 | $0.85 | — | ||
| Q4 25 | $1.28 | $0.82 | ||
| Q3 25 | $0.98 | $0.67 | ||
| Q2 25 | $1.06 | $0.96 | ||
| Q1 25 | $1.23 | $0.49 | ||
| Q4 24 | $1.58 | $0.28 | ||
| Q3 24 | $1.02 | $0.61 | ||
| Q2 24 | $0.93 | $0.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $41.0M |
| Total DebtLower is stronger | $10.1B | $5.1B |
| Stockholders' EquityBook value | $10.7B | $4.3B |
| Total Assets | $37.1B | $13.9B |
| Debt / EquityLower = less leverage | 0.95× | 1.18× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | $41.0M | ||
| Q3 25 | $4.0B | $56.0M | ||
| Q2 25 | $3.7B | $61.0M | ||
| Q1 25 | $2.5B | $101.0M | ||
| Q4 24 | $2.9B | $59.0M | ||
| Q3 24 | $3.5B | $81.0M | ||
| Q2 24 | $2.0B | $405.0M |
| Q1 26 | $10.1B | — | ||
| Q4 25 | $10.0B | $5.1B | ||
| Q3 25 | $10.3B | $4.8B | ||
| Q2 25 | $10.3B | $4.7B | ||
| Q1 25 | $8.8B | $4.7B | ||
| Q4 24 | $9.0B | $4.8B | ||
| Q3 24 | $10.3B | $4.7B | ||
| Q2 24 | $9.2B | $4.6B |
| Q1 26 | $10.7B | — | ||
| Q4 25 | $10.4B | $4.3B | ||
| Q3 25 | $10.0B | $4.5B | ||
| Q2 25 | $9.7B | $4.6B | ||
| Q1 25 | $9.2B | $4.6B | ||
| Q4 24 | $8.4B | $4.5B | ||
| Q3 24 | $8.3B | $4.6B | ||
| Q2 24 | $7.8B | $5.0B |
| Q1 26 | $37.1B | — | ||
| Q4 25 | $36.9B | $13.9B | ||
| Q3 25 | $36.1B | $14.0B | ||
| Q2 25 | $35.5B | $13.8B | ||
| Q1 25 | $33.6B | $13.7B | ||
| Q4 24 | $33.1B | $13.4B | ||
| Q3 24 | $33.9B | $13.5B | ||
| Q2 24 | $31.9B | $13.7B |
| Q1 26 | 0.95× | — | ||
| Q4 25 | 0.96× | 1.18× | ||
| Q3 25 | 1.03× | 1.08× | ||
| Q2 25 | 1.06× | 1.02× | ||
| Q1 25 | 0.95× | 1.02× | ||
| Q4 24 | 1.06× | 1.06× | ||
| Q3 24 | 1.24× | 1.01× | ||
| Q2 24 | 1.18× | 0.92× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $293.0M |
| Free Cash FlowOCF − Capex | $112.0M | $159.0M |
| FCF MarginFCF / Revenue | 2.2% | 1.6% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | 1.59× |
| TTM Free Cash FlowTrailing 4 quarters | — | $959.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $293.0M | ||
| Q3 25 | — | $351.0M | ||
| Q2 25 | $94.0M | $334.0M | ||
| Q1 25 | $250.0M | $391.0M | ||
| Q4 24 | — | $283.0M | ||
| Q3 24 | — | $270.0M | ||
| Q2 24 | $-119.0M | $482.0M |
| Q1 26 | $112.0M | — | ||
| Q4 25 | — | $159.0M | ||
| Q3 25 | — | $236.0M | ||
| Q2 25 | $8.0M | $257.0M | ||
| Q1 25 | $98.0M | $307.0M | ||
| Q4 24 | — | $178.0M | ||
| Q3 24 | — | $190.0M | ||
| Q2 24 | $-183.0M | $413.0M |
| Q1 26 | 2.2% | — | ||
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | 0.2% | 2.5% | ||
| Q1 25 | 2.1% | 3.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | -3.8% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 1.4% | ||
| Q3 25 | 2.1% | 1.1% | ||
| Q2 25 | 1.7% | 0.8% | ||
| Q1 25 | 3.2% | 0.9% | ||
| Q4 24 | 1.9% | 1.1% | ||
| Q3 24 | 1.9% | 0.8% | ||
| Q2 24 | 1.3% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.59× | ||
| Q3 25 | — | 2.29× | ||
| Q2 25 | 0.19× | 1.49× | ||
| Q1 25 | 0.44× | 3.40× | ||
| Q4 24 | — | 4.29× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | -0.28× | 2.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
USFD
| Product One | $3.5B | 36% |
| Product Two | $1.7B | 17% |
| Product Three | $1.7B | 17% |
| Product Four | $985.0M | 10% |
| Product Five | $901.0M | 9% |
| Product Six | $580.0M | 6% |
| Product Seven | $485.0M | 5% |
